| Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome (NCT07316595) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2025-12-30 |
| Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma (NCT07375563) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2025-11-19 |
| Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies (NCT07366801) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2025-09-03 |
| The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia (NCT07232134) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2025-07-24 |
| Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation (NCT07256210) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2025-05-09 |
| Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis (NCT06587191) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2024-08-01 |
| Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis (NCT06756152) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2024-07-10 |
| Successful Treatment of Netherton Syndrome With Combination of Secukinumab and Dupilumab (NCT07151508) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-12-19 |
| Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis (NCT06475820) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-12-01 |
| Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome (NCT06198842) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-11-22 |
| PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity (NCT06199427) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-11-21 |
| Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification (NCT06296732) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-10-19 |
| Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma (NCT06071897) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-09-01 |
| Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies (NCT05986734) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2022-09-01 |
| Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis (NCT05515029) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2022-08-23 |
| Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA) (NCT05549167) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2022-05-30 |
| B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 (NCT05518383) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2022-05-25 |
| Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents (NCT05346731) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2022-04-01 |
| Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021) (NCT05029531) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-09-23 |
| Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT (NCT05066958) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-09-16 |
| Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia (NCT04844177) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-04-14 |
| Videoocular Assessment of Eye Movement Activity in an Ataxia Telangiectasia (NCT05471310) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-03-15 |
| Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia (NCT04767165) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-02-22 |
| Evaluation of Brain Changes in ALL Patients on Therapy (NCT04767152) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-02-16 |
| Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy (NCT04761965) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-02-16 |
| DWI in the Diagnosis of Histological Types of Nephroblastoma in Children (NCT04814758) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-12-21 |
| Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT) (NCT04593368) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-12-15 |
| Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies. (NCT04572620) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-09-07 |
| Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL (NCT04499573) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-07-27 |
| Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome (NCT04400045) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-05-22 |
| Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I) (NCT05330832) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-04-01 |
| Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot (NCT04723342) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-02-01 |
| MRI T2* Mapping of Myocardium, Liver, Pancreas and Pituitary Gland (NCT04835285) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-01-21 |
| Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome (NCT04371939) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-11-05 |
| Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias (NCT04000698) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-10-15 |
| Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT) (NCT03474133) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-05-14 |
| Modification of the Human Colon and Oral Microbiome by Allogenic HSCT (NCT03942159) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-05-14 |
| Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients (NCT03547830) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-04-13 |
| A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML (NCT03846362) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-04-01 |
| Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors (NCT03874273) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-02-01 |
| Metabolic Syndrome in Childhood Cancer Survivors (NCT03773718) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-11-20 |
| the Efficacy and Safety of Sugammadex in Children 0-2 Years Old (NCT03728543) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-11-15 |
| A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation (NCT03585686) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-06-26 |
| CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL (NCT03467256) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-05-14 |
| Clinical Use of Pathogen Reduced Red Blood Cell Suspension (NCT03426553) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-01-15 |
| Cognitive and Motor Training in Pediatric Posterior Fossa Tumor Survivors (NCT03951246) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2017-11-01 |
| Creating a Decision Support System for the Corporate Management of Physical Therapy (NCT03586401) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2017-11-01 |
| Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA (NCT03413306) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2016-12-10 |
| CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT (NCT02942173) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2016-10-01 |
| A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients (NCT03019809) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2016-06-01 |
| Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015) (NCT03390387) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2015-11-01 |
| IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease (NCT04136028) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2015-09-25 |
| Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation (NCT02337595) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2014-08-01 |
| TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID (NCT02327351) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2012-07-01 |
| Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome. (NCT04350164) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2012-04-01 |
| Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 (NCT01953770) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2008-02-01 |